Cetuxa 100mg Cetuximab Price USA | Ernest Oncology Indian Exporter

Cetuxa 100mg Injection: Targeted Cetuximab Therapy for Advanced Oncology Care

Are you searching for a reliable Cetuxa 100 mg injection exporter from India? Ernest Oncology, a specialized division of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of advanced monoclonal antibodies. We maintain a high-authority, regulatory-compliant supply chain serving the USA, UK, Australia, and South Africa, ensuring that life-saving medications reach healthcare providers with pharmaceutical-grade integrity and efficient global logistics.

Detailed Product Overview: What is Cetuxa 100mg?

Cetuxa 100mg is a potent intravenous injection containing the active pharmaceutical ingredient Cetuximab. It is a recombinant, chimeric monoclonal antibody that specifically binds to the Epidermal Growth Factor Receptor (EGFR). By inhibiting this receptor, Cetuxa disrupts the signaling pathways that allow cancer cells to grow, multiply, and spread to other parts of the body.

Manufactured by Alkem Laboratories Ltd., a global leader in pharmaceuticals, Cetuxa 100mg is designed for high-precision oncology. It is a critical therapeutic option for patients with malignancies that overexpress EGFR, providing a world-class, cost-effective alternative for international B2B procurement without compromising clinical outcomes.

Primary Therapeutic Indications

Cetuxa 100 mg Injection is clinically indicated for the management of:

1. Metastatic Colorectal Cancer (mCRC): Specifically for patients with EGFR-expressing, RAS wild-type tumors. It is used as a standalone therapy or in combination with chemotherapy regimens like FOLFIRI or FOLFOX.

2. Squamous Cell Carcinoma of the Head and Neck (SCCHN):

   • In combination with radiation therapy for locally or regionally advanced disease.

   • In combination with platinum-based chemotherapy for recurrent or metastatic disease.

   • As a single agent for patients who have progressed after platinum-based therapy.

Mechanism of Action: How Cetuxa 100mg Works

Cetuxa operates through a highly targeted biochemical mechanism:

• EGFR Competitive Binding: Cetuxa binds to the extracellular domain of the Epidermal Growth Factor Receptor (EGFR) with higher affinity than natural ligands like EGF.

• Signal Blockade: This binding prevents the activation of the receptor, effectively "switching off" the internal signaling pathways (MAPK, PI3K, and Akt) responsible for cell proliferation and survival.

• Angiogenesis Inhibition: It reduces the production of vascular endothelial growth factor (VEGF), limiting the blood supply the tumor needs to grow.

• Immune Activation (ADCC): As a monoclonal antibody, it flags cancer cells for destruction by the body’s own immune effector cells (Antibody-Dependent Cell-Mediated Cytotoxicity).

Administration and Safety Guidelines

• Administration: Cetuxa 100mg must be administered via intravenous (IV) infusion by a trained oncology nurse or physician. Self-administration is strictly prohibited.

• Infusion Rates: The initial loading dose is typically infused over 120 minutes, while subsequent weekly maintenance doses are infused over 60 minutes.

• Pre-medication: To prevent infusion-related reactions, patients are often pre-treated with an antihistamine (like diphenhydramine) and a corticosteroid.

• Key Precautions:

  • Dermatologic Toxicity: A common side effect is an acne-like rash; patients should avoid excessive sun exposure.

  • Electrolyte Monitoring: Regular monitoring of serum magnesium, calcium, and potassium is required, as hypomagnesemia is a frequent side effect.

  • Cardiopulmonary Risks: Patients with a history of lung or heart disease should be monitored closely for infusion reactions.

Why Source Cetuxa 100 mg from Ernest Oncology?

• Strategic Indian Exporter: Direct partnership with GMP-certified manufacturing hubs, ensuring 100% authenticity and competitive bulk pricing for the international market.

• Cold-Chain Expertise: Advanced logistics management to maintain the strict 2°C to 8°C temperature range required for biologics during transit to the USA, UK, Australia, and South Africa.

• Global Supply Continuity: We specialize in fulfilling large-scale orders for oncology hospitals, specialty clinics, and regional distributors, ensuring treatment stability.

• Regulatory Compliance: Every shipment is accompanied by a Certificate of Analysis (COA) and verified documentation to facilitate seamless customs clearance.